• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与原位黑色素瘤的临床扩散相关的临床因素。

Clinical factors associated with subclinical spread of in situ melanoma.

机构信息

Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J Am Acad Dermatol. 2017 Apr;76(4):707-713. doi: 10.1016/j.jaad.2016.10.049. Epub 2017 Jan 7.

DOI:10.1016/j.jaad.2016.10.049
PMID:28073583
Abstract

BACKGROUND

Subclinical spread of in situ melanoma occurs at a wide frequency, ranging from 12% to 71%.

OBJECTIVE

To identify clinical factors associated with subclinical spread of in situ melanoma.

METHODS

We used a retrospective, cross-sectional study of 674 consecutive in situ melanomas to examine 627 patients treated with Mohs surgery and melanoma antigen recognized by T cells 1 immunostaining. The presence of subclinical spread was correlated with clinical characteristics. Univariate and multivariate logistic regression analyses were performed to generate odds ratios (ORs) and 95% confidence intervals (CIs).

RESULTS

Both univariate and multivariate analyses demonstrated significantly increased odds for subclinical spread of in situ melanomas when they were located on the head or neck, at acral sites, or on the pretibial leg (OR 1.97, 95% CI 1.41-3.40); in persons with a history of prior treatment (OR 2.77, 95% CI 1.74-4.420); melanomas of preoperative size >1 cm (OR 1.74, 95% CI 1.23-2.46, P = .002); or in persons ≥60 years old (OR 1.47, 95% CI 1.01-2.13, P = .042). A count prediction model demonstrated that the risk for subclinical spread increased with the number of clinical risk factors.

LIMITATION

We used a single-site, retrospective study design.

CONCLUSION

Clarifying the risk factors for subclinical spread might help to refine triage of in situ melanomas to the appropriate surgical techniques for margin assessment prior to reconstruction.

摘要

背景

原位黑素瘤的亚临床扩散频率广泛,为 12%至 71%。

目的

确定与原位黑素瘤亚临床扩散相关的临床因素。

方法

我们对 674 例连续的原位黑素瘤进行了回顾性、横断面研究,共检查了 627 例接受 Mohs 手术和黑色素瘤抗原识别 T 细胞 1 免疫染色的患者。将亚临床扩散的存在与临床特征相关联。进行了单变量和多变量逻辑回归分析,以生成优势比(OR)和 95%置信区间(CI)。

结果

单变量和多变量分析均表明,当原位黑素瘤位于头颈部、肢端部位或小腿前侧、既往有治疗史、术前大小>1cm 或患者年龄≥60 岁时,其亚临床扩散的可能性显著增加(OR 分别为 1.97、2.77、1.74、1.74,95%CI 分别为 1.41-3.40、1.74-4.420、1.23-2.46、1.01-2.13,P 均<0.05)。计数预测模型表明,亚临床扩散的风险随临床危险因素数量的增加而增加。

局限性

我们使用了单站点、回顾性研究设计。

结论

阐明亚临床扩散的风险因素可能有助于在重建前对适当的手术技术进行边缘评估,从而对原位黑素瘤进行分诊。

相似文献

1
Clinical factors associated with subclinical spread of in situ melanoma.与原位黑色素瘤的临床扩散相关的临床因素。
J Am Acad Dermatol. 2017 Apr;76(4):707-713. doi: 10.1016/j.jaad.2016.10.049. Epub 2017 Jan 7.
2
Clinical and pathologic factors associated with subclinical spread of invasive melanoma.与侵袭性黑色素瘤临床和病理因素相关的亚临床扩散。
J Am Acad Dermatol. 2017 Apr;76(4):714-721. doi: 10.1016/j.jaad.2016.11.048. Epub 2017 Jan 28.
3
Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.伴有 T 细胞 1 识别的黑色素瘤抗原(MART-1)免疫染色的不典型表皮内黑素细胞增殖的 Mohs 显微外科手术。
J Am Acad Dermatol. 2018 Dec;79(6):1109-1116.e1. doi: 10.1016/j.jaad.2018.06.058. Epub 2018 Jul 10.
4
Comparison of surgical margins for lentigo maligna versus melanoma in situ.比较分析恶性雀斑样痣与原位黑素瘤的手术切缘。
J Am Acad Dermatol. 2019 Jul;81(1):204-212. doi: 10.1016/j.jaad.2019.01.051. Epub 2019 Apr 20.
5
The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.在躯干和近端肢体原位黑色素瘤(MIS)中使用Mohs 显微外科手术(MMS)。
J Am Acad Dermatol. 2016 Nov;75(5):1015-1021. doi: 10.1016/j.jaad.2016.06.033. Epub 2016 Jul 26.
6
Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.在澳大利亚采用莫氏显微外科手术治疗原位黑色素瘤和恶性雀斑样痣。
Australas J Dermatol. 2019 Feb;60(1):33-37. doi: 10.1111/ajd.12845. Epub 2018 Jun 22.
7
Utility of teledermatopathology for intraoperative margin assessment of melanoma in situ, lentigo maligna type: A 6 year community practice experience.远程皮肤病理在评估原位黑色素瘤、恶性雀斑样痣型术中切缘的应用:一项 6 年社区实践经验。
Eur J Surg Oncol. 2021 May;47(5):1140-1144. doi: 10.1016/j.ejso.2020.09.018. Epub 2020 Sep 22.
8
Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.在 Mohs 显微外科手术中,对于原位性恶性雀斑样痣和黑色素瘤,切除标本的垂直病理学的重要性。
Dermatol Surg. 2013 Mar;39(3 Pt 1):365-71. doi: 10.1111/dsu.12078. Epub 2013 Jan 28.
9
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.传统手术与慢速莫氏显微描记手术治疗恶性雀斑的比较:62例回顾性研究
Actas Dermosifiliogr. 2012 Sep;103(7):614-23. doi: 10.1016/j.ad.2011.12.009. Epub 2012 May 7.
10
Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.眼部恶性雀斑及恶性雀斑样黑色素瘤的映射连续切除术
Ophthalmology. 2003 Oct;110(10):2011-8. doi: 10.1016/S0161-6420(03)00670-5.

引用本文的文献

1
Incomplete Excision Rate for Lentigo Maligna and Associated Risk Factors.恶性雀斑样痣的不完全切除率及相关危险因素。
Acta Derm Venereol. 2024 Oct 3;104:adv40535. doi: 10.2340/actadv.v104.40535.
2
Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.原位黑色素瘤:当前切除边缘推荐的批判性回顾和再评估。
Adv Ther. 2021 Jul;38(7):3506-3530. doi: 10.1007/s12325-021-01783-x. Epub 2021 May 28.
3
Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.临床大小是预测恶性雀斑样痣型黑素瘤侵袭的不良指标。
J Am Acad Dermatol. 2021 May;84(5):1295-1301. doi: 10.1016/j.jaad.2020.10.023. Epub 2020 Oct 20.
4
Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.利用反射共聚焦显微镜对恶性黑色素瘤进行定位与分期切除相关:一项前瞻性研究。
J Am Acad Dermatol. 2023 Feb;88(2):371-379. doi: 10.1016/j.jaad.2019.11.058. Epub 2019 Dec 5.
5
Current perspectives on Mohs micrographic surgery for melanoma.黑色素瘤的莫氏显微外科手术的当前观点
Clin Cosmet Investig Dermatol. 2018 Jun 20;11:309-320. doi: 10.2147/CCID.S137513. eCollection 2018.
6
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.银屑病与皮肤肿瘤学最新进展:2017年毛伊岛皮肤科学术会议论文集
J Clin Aesthet Dermatol. 2017 Sep;10(9 Suppl):S8-S41. Epub 2017 Sep 1.